Inhaled nitric oxide in cardiology (Q34481821)

2 August 2017

1 reference

title

Inhaled nitric oxide in cardiology (English)

1 reference

2 August 2017

Hayward CS

1

1 reference

2 August 2017

Macdonald PS

series ordinal

2

1 reference

2 August 2017

Keogh AM

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

1 reference

2 August 2017

10

1 reference

2 August 2017

1947-1956

1 reference

2 August 2017

11

1 reference

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

2 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Formation of nanomolar concentrations of S-nitroso-albumin in human plasma by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Biotransformation of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Conversion of inhaled nitric oxide to nitrate in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Gas-phase oxidation of nitric oxide: chemical kinetics and rate constant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Formation of nitrogen dioxide from nitric oxide and their measurement in clinically relevant circumstances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Factors influencing indoor concentrations of nitric oxide in a Parisian intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Myocardial contractile response to nitric oxide and cGMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Inotropic effects of glyceryl trinitrate and spontaneous NO donors in the dog heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Rebound pulmonary hypertension after inhalation of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Life-threatening effects of discontinuing inhaled nitric oxide in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Negative feedback regulation of endothelial cell function by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Inhaled nitric oxide in patients with severe heart failure: changes in lung perfusion and ventilation detected using scintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Nitric oxide gives maximal response after coronary artery bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Inhaled nitric oxide improves hemodynamics in patients with acute pulmonary hypertension after high-risk cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Nitric oxide inhalation in the treatment of primary graft failure following heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Inhaled nitric oxide in congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Inhaled nitric oxide differentiates pulmonary vasospasm from vascular obstruction after surgery for congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Response to inhaled nitric oxide in patients with acute right heart syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Selective pulmonary vasodilation induced by aerosolized zaprinast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Sildenafil inhibits hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Paradoxical fate and biological action of peroxynitrite on human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Inhaled nitric oxide increases coronary artery patency after thrombolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.11.1947

10.1517/13543784.10.11.1947

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference